相关实验视频
Updated: Jul 12, 2025

10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
18.5K
炎症标志物,临床特征和精神分裂症未服用药物的患者的认知表现之间的关系
Xiaoxiao Sun1, Guoshuai Luo1, Xue Li1
1Laboratory of Biological Psychiatry, Institute of Mental Health, Tianjin Anding Hospital, Tianjin Medical University, 13 Liulin Road, Hexi District, Tianjin, 300222, China.
European archives of psychiatry and clinical neuroscience
|October 30, 2023
概括
在精神分裂症患者中,中性粒细胞凝酶相关的炎症标志物利波卡林 (NGAL) 和干扰素-γ (IFN-γ) 较低. 较高的NGAL和IFN-γ水平与更好的认知功能和精神分裂症中较少的积极症状相关.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 免疫学 免疫学 免疫学
背景情况:
- 精神分裂症的病理生理学涉及炎症因素.
- 炎症标志物和精神分裂症症状尺寸/认知功能之间的联系尚不清楚.
研究的目的:
- 研究血S-100B,NGAL和IFN-γ水平与精神分裂症症状尺寸和认知功能之间的关联.
- 确定精神分裂症诊断和认知障碍的潜在生物标志物.
主要方法:
- 140名以前没有服用过药物的精神分裂症患者和69名健康对照人被纳入.
- 使用ELISA测量了S100B,NGAL和IFN-γ的血度.
- 评估了精神病症状 (PANSS) 和认知功能 (MCCB).
主要成果:
- 与对照组相比,精神分裂症患者的认知功能较差,NGAL/IFN-γ水平较低.
- NGAL和IFN-γ水平与积极症状负相关,与认知功能正相关 (MCCB总分).
- NGAL水平和负症状得分是MCCB总得分的独立预测因素;NGAL是精神分裂症诊断的独立风险因素.
结论:
- NGAL和IFN-γ与精神分裂症的认知功能和症状维度有关.
- NGAL可能是认知功能的保护因素,也是精神分裂症诊断的危险因素.
- 这些发现强调了炎症在精神分裂症中的作用,并提出了潜在的治疗点.
相关概念视频
Negative and Cognitive Symptoms of Schizophrenia
50
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
50
Psychological and Sociocultural Causes of Schizophrenia
92
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
92
Psychosis: Goals of Pharmacotherapy
145
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
145
Psychosis and Antipsychotic Drugs: Overview
290
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
290
Biological Causes of Schizophrenia
61
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
61
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
131
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
131

